235 related articles for article (PubMed ID: 37284446)
1. The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure.
Fu Y; Xiang Y; Wang Y; Liu Z; Yang D; Zha J; Tang C; Cai J; Chen G; Dong Z
Theranostics; 2023; 13(9):2757-2773. PubMed ID: 37284446
[No Abstract] [Full Text] [Related]
2. p53/sirtuin 1/NF-κB Signaling Axis in Chronic Inflammation and Maladaptive Kidney Repair After Cisplatin Nephrotoxicity.
Fu Y; Wang Y; Liu Y; Tang C; Cai J; Chen G; Dong Z
Front Immunol; 2022; 13():925738. PubMed ID: 35874713
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress contributes to cisplatin-induced chronic kidney disease via the PERK-PKCδ pathway.
Shu S; Wang H; Zhu J; Fu Y; Cai J; Chen A; Tang C; Dong Z
Cell Mol Life Sci; 2022 Jul; 79(8):452. PubMed ID: 35895146
[TBL] [Abstract][Full Text] [Related]
4. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity.
Li S; Livingston MJ; Ma Z; Hu X; Wen L; Ding HF; Zhou D; Dong Z
JCI Insight; 2023 Apr; 8(8):. PubMed ID: 36917180
[TBL] [Abstract][Full Text] [Related]
5. p53 in Proximal Tubules Mediates Chronic Kidney Problems after Cisplatin Treatment.
Fu S; Hu X; Ma Z; Wei Q; Xiang X; Li S; Wen L; Liang Y; Dong Z
Cells; 2022 Feb; 11(4):. PubMed ID: 35203361
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity.
Hu X; Ma Z; Li S; Wen L; Huo Y; Wu G; Manicassamy S; Dong Z
Lab Invest; 2023 Mar; 103(3):100009. PubMed ID: 36925200
[TBL] [Abstract][Full Text] [Related]
7. Single-Nucleus Transcriptional Profiling of Chronic Kidney Disease after Cisplatin Nephrotoxicity.
Ma Z; Hu X; Ding HF; Zhang M; Huo Y; Dong Z
Am J Pathol; 2022 Apr; 192(4):613-628. PubMed ID: 35092726
[TBL] [Abstract][Full Text] [Related]
8. Persistent Activation of Autophagy After Cisplatin Nephrotoxicity Promotes Renal Fibrosis and Chronic Kidney Disease.
Fu Y; Xiang Y; Wu W; Cai J; Tang C; Dong Z
Front Pharmacol; 2022; 13():918732. PubMed ID: 35707397
[TBL] [Abstract][Full Text] [Related]
9. Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways.
Michel HE; Menze ET
Eur J Pharmacol; 2019 Aug; 857():172422. PubMed ID: 31152701
[TBL] [Abstract][Full Text] [Related]
10. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
Yu X; Meng X; Xu M; Zhang X; Zhang Y; Ding G; Huang S; Zhang A; Jia Z
EBioMedicine; 2018 Oct; 36():266-280. PubMed ID: 30268831
[TBL] [Abstract][Full Text] [Related]
11. NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells.
Poveda J; Sanz AB; Rayego-Mateos S; Ruiz-Ortega M; Carrasco S; Ortiz A; Sanchez-Niño MD
Biochim Biophys Acta; 2016 Apr; 1862(4):635-646. PubMed ID: 26776679
[TBL] [Abstract][Full Text] [Related]
12. An herbal formulation "Shenshuaifu Granule" alleviates cisplatin-induced nephrotoxicity by suppressing inflammation and apoptosis through inhibition of the TLR4/MyD88/NF-κB pathway.
Jin X; He R; Liu J; Wang Y; Li Z; Jiang B; Lu J; Yang S
J Ethnopharmacol; 2023 Apr; 306():116168. PubMed ID: 36646160
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatocyte nuclear factor 1β contributes to cisplatin nephrotoxicity via regulation of nf-κb pathway.
Zhang Y; Hao J; Du Z; Li P; Hu J; Ruan M; Li S; Ma Y; Lou Q
J Cell Mol Med; 2021 Mar; 25(6):2861-2871. PubMed ID: 33512774
[TBL] [Abstract][Full Text] [Related]
14. Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.
Wen L; Tao SH; Guo F; Li LZ; Yang HL; Liang Y; Zhang LD; Ma L; Fu P
Acta Pharmacol Sin; 2022 Aug; 43(8):2067-2080. PubMed ID: 34937916
[TBL] [Abstract][Full Text] [Related]
15. Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury.
Xie D; Hu G; Chen C; Ahmadinejad F; Wang W; Li PL; Gewirtz DA; Li N
Am J Physiol Renal Physiol; 2022 Sep; 323(3):F322-F334. PubMed ID: 35834271
[TBL] [Abstract][Full Text] [Related]
16. NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI).
Ozkok A; Ravichandran K; Wang Q; Ljubanovic D; Edelstein CL
Toxicol Lett; 2016 Jan; 240(1):105-13. PubMed ID: 26546572
[TBL] [Abstract][Full Text] [Related]
17. Divergent effects of AKI to CKD models on inflammation and fibrosis.
Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
[TBL] [Abstract][Full Text] [Related]
18. Intrarenal modulation of NF-κB activity attenuates cardiac injury in a swine model of CKD: a renal-cardio axis.
Chade AR; Engel JE; Hall ME; Eirin A; Bidwell GL
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F411-F423. PubMed ID: 34396789
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-κB signaling pathway.
Li YY; Feng YP; Liu L; Ke J; Long X
Eur J Histochem; 2022 Jun; 66(3):. PubMed ID: 35726537
[TBL] [Abstract][Full Text] [Related]
20. Soluble thrombomodulin alleviates Diquat-induced acute kidney injury by inhibiting the HMGB1/IκBα/NF-κB signalling pathway.
Huang S; Lin S; Zhou S; Huang Z; Li Y; Liu S; Liu R; Luo X; Li J; Yang J; Yuan Z
Food Chem Toxicol; 2023 Aug; 178():113871. PubMed ID: 37277018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
